Latest 12 months Revenue for Nektar Therapeutics is Down -51.98% according to T12-NEWS
Stock Quote:(NasdaqNM:NKTR)
11/10/2009
11.71
0.00
0.00%
0
Latest 12 months Revenue for Nektar Therapeutics is Down -51.98% according to T12-NEWS
Last
Price Change
% Chg
Volume
New York, NY, November 10, 2009,T12-NEWS reports that Revenue for Nektar Therapeutics (NASDAQ:NKTR) for its trailing twelve months (TTM) ended September 30, 2009 was $61,274,000, a -51.98% decrease ov ... read full story
Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story